Costs for integrated histomolecular diagnostic work-up may be significant and in many countries currently not or only partially reimbursed by health care providers.
← all excerpts
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.
1
—
—